France's Drug Risk List Could Prompt Patients To Seek Alternatives
This article was originally published in The Pink Sheet Daily
Executive Summary
The French Medicines Agency has published a list of potentially problematic medicines, seeking to reassure the public of its pharmacovigilance efforts in the wake of the Mediator scandal. It may not have the intended effect.